Skip to content
Trial Eligibility
Menu

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

NCT06315179

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort of pediatric patients with disorders of the brain-gut interactions (DBGI) with no detectable gut inflammation.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Inflammatory Bowel Diseases
  • Crohn Disease
  • Ulcerative Colitis
  • Indeterminate Colitis
  • Functional Abdominal Pain Syndrome
  • Functional Bowel Disorder
  • Esophageal Diseases
  • Gastroduodenal Disorder
  • Bowel Dysfunction
  • Gallbladder Diseases
  • Sphincter of Oddi Dysfunction
  • Anorectal Disorder

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
6 to 21 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Seattle Children's Hospital
Last updated on ClinicalTrials.gov
April 24, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Washington · 1

  • Seattle Children's Hospital · Seattle, WA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.